Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


4 Cephalalgia
1 Headache
1 Neurology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. BEN AISSA M, Tipton AF, Bertels Z, Gandhi R, et al
    Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
    Cephalalgia. 2017 Jan 1:333102417737778. doi: 10.1177/0333102417737778.
    PubMed     Text format     Abstract available

  2. SPIERINGS EL, Brandes JL, Kudrow DB, Weintraub J, et al
    Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
    Cephalalgia. 2017 Jan 1:333102417737765. doi: 10.1177/0333102417737765.
    PubMed     Text format     Abstract available

  3. EDVINSSON L, Warfvinge K
    Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
    Cephalalgia. 2017 Jan 1:333102417736900. doi: 10.1177/0333102417736900.
    PubMed     Text format     Abstract available

  4. LEBEDEVA ER, Gurary NM, Gilev DV, Christensen AF, et al
    Explicit diagnostic criteria for transient ischemic attacks to differentiate it from migraine with aura.
    Cephalalgia. 2017 Jan 1:333102417736901. doi: 10.1177/0333102417736901.
    PubMed     Text format     Abstract available


  5. LIPTON RB, Reed ML, Kurth T, Fanning KM, et al
    Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Headache. 2017 Oct 9. doi: 10.1111/head.13179.
    PubMed     Text format     Abstract available


  6. PALM-MEINDERS IH, Arkink EB, Koppen H, Amlal S, et al
    Volumetric brain changes in migraineurs from the general population.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004640.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.